The story of Sildenafil presents a intricate picture for investors. While the initial release generated massive profits, the expiration of its patent opened the door to cheaper versions, dramatically eroding sales. https://bookmark-nation.com/story21460015/the-copyright-and-the-pharmaceutical-industry-a-risky-opportunity